Description: AlphaGen Therapeutics is pioneering the discovery, development and commercialization of innovative radioligand therapies (RLTs). With our cutting-edge technology platform, we are developing a new class of alpha RLTs for patients in China and around the world.
alphagen therapeutics (1) alphagen (1)
Next-Generation Targeted Radioligand Therapies for Cancer Patients
AlphaGen Therapeutics is pioneering the discovery, development and commercialization of innovative radioligand therapies (RLTs). With our cutting-edge technology platform, we are developing a new class of alpha RLTs for patients in China and around the world.
AlphaGen has secured a next-generation Pb-212 isolation technology that is strongly positioned to build a leading radiopharmaceutical platform in China.